Physicians weigh in on long-term use of IBD treatments

06/17/2013 | Gastroenterology & Endoscopy News

Patients with inflammatory bowel disease may want to discontinue treatment once they achieve remission but Dr. David Rubin of the Inflammatory Bowel Disease Center at the University of Chicago says it is important to remember IBD is a chronic disease and stopping therapy can lead to recurrence. Physicians say there are limited data on even de-escalating treatments. There may be some cases in which scaling back is appropriate, but the science is still emerging, Rubin and others said.

View Full Article in:

Gastroenterology & Endoscopy News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health